Contractor Notice: SSP04: Haloperidol 500mcg capsules expired

Contractor Notice: SSP04: Haloperidol 500mcg capsules expired

March 24, 2020

Following the implementation of SSP04, DHSC has announced that sufficient stock of Haloperidol 500mcg capsules is now available to supply normal demand; as a result the SSP04 for Haloperidol 500mcg capsules expired at 23.55pm Monday 23rd March 2020. Any prescriptions for Haloperidol 500mcg capsules after this date must be dispensed in accordance with the prescription, as the SSP will no longer be valid for use.

Top Tips

  • View our SSP submission reminder to ensure your SSP claims are appropriately submitted to NHSBSA  for reimbursement.
  • Pharmacy teams are advised to submit SSP claims using the EPS token if your PMR systems do not support/capture all the SSP endorsement requirements for a valid claim.
  • If using a token to submit SSP claims, to avoid double-claiming, remember to mark the item covered by the SSP as ‘Not Dispensed’/’ND’ on the EPS message.
  • Where available, use the claim amend facility on your PMR system to rectify any incorrect EPS claims already submitted this month.
  • Any paper prescriptions or tokens with SSP claims need to be placed in a red separator (and kept separate from other tokens for non-payment i.e. with paid/exempt status).
  • Check that the correct number of patient charges are collected and declared on the end of month FP34C submission form.
  • SSPs will be accepted for up to three calendar months after expiry or withdrawal of the SSP. For example, for the Haloperidol 500mcg capsules SSP, which was withdrawn on 23rd March, the NHSBSA would look for the “NCSO” endorsement in the March batch (submitted by the 5th of April), April batch (submitted by the 5th May) and May batch (submitted by the 5th of June).
  • NHSBSA advise that contractor SSP claims should be clear and unambiguous and follow the protocol guidelines – NHSBSA processing staff must be able to determine what has been supplied.
  • Pharmacy contractors should keep a record of all SSP claims and reconcile when their Schedule of Payments are sent.

Additional information

On 22nd Decmber it was announced that the Secretary of State had authorised a Serious Shortage Protocol (SSP) to help manage the supply of Haloperidol 500mcg capsules. This SSP was put in place to manage stock and to try to ensure that fewer patients have to return to their prescriber.

View PSNC’s SSP FAQ page here.

View NHSBSA’s support guidance to endorsing Haloperidol SSPs here.

To view the latest SSP updates visit:


Posted in: ,

More Latest News >

PSNC launches GP CPCS animation

PSNC has launched a video animation and infographic explaining how GP practices can refer into the NHS Community Pharmacist Consultation...